Live feed
Filing
SC 13G/A
SC 13G/A0001213900-16-015549·Theravance Biopharma, Inc.
Schedule 13G ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: 2016-07-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-16-015549
- Form type
- SC 13G/A
- Filer
- Theravance Biopharma, Inc.
- CIK
- CIK 1583107
- Filed
- Aug 04, 2016
- Reporting period
- Jul 01, 2016
- Description
- Schedule 13G beneficial ownership